"Consumer Health in France" Now Available at Fast Market Research
De-reimbursement continued throughout 2011-2012, generating slight current value growth of 1% for consumer health, along with the downwards trend of prescriptions. Value growth in consumer health was strongly linked to the price rises that resulted from de-reimbursement, and also to the high propensity of medical practitioners to prescribe partially refunded yet OTC medicines. With the arrival of the socialist government in May 2012, de-reimbursement continued, and a total of 60 drugs (mostly...
View full press release